FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2091201553> ?p ?o ?g. }

• W2091201553 endingPage "477" @default.
• W2091201553 startingPage "473" @default.
• W2091201553 abstract "Tumor-infiltrating lymphocytes (TILs) are cells generated from tumor suspensions cultured in interleukin 2 that can mediate cancer regression when adoptively transferred into mice or humans. Since TILs proliferate rapidly in vitro, recirculate, and preferentially localize at the tumor site in vivo, they provide an attractive model for delivery of exogenous genetic material into man. To determine whether efficient gene transfer into TILs is feasible, we transduced human TILs with the bacterial gene for neomycin-resistance (NeoR) using the retroviral vector N2. The transduced TIL populations were stable and polyclonal with respect to the intact NeoR gene integration and expressed high levels of neomycin phosphotransferase activity. The NeoR gene insertion did not alter the in vitro growth pattern and interleukin 2 dependence of the transduced TILs. Analyses of T-cell receptor gene rearrangement for beta- and gamma-chain genes revealed the oligoclonal nature of the TIL populations with no major change in the DNA rearrangement patterns or the levels of mRNA expression of the beta and gamma chains following transduction and selection of TILs in the neomycin analog G418. Human TILs expressed mRNA for tumor necrosis factors (alpha and beta) and interleukin 2 receptor P55 but not for interleukin 1 beta, granulocyte/macrophage colony-stimulating factor, interleukin 6, and interferon gamma when grown with high-dose interleukin 2 without subsequent activation with mitogen or specific antigen. This pattern of cytokine-mRNA expression was not significantly altered following the transduction of TILs. The NeoR gene-transduced TILs could thus be used to follow the trafficking and survival of TILs in vivo, and clinical protocols using these transduced TILs in cancer patients have begun. The studies demonstrate the feasibility of TILs as suitable cellular vehicles for the introduction of therapeutic genes into patients receiving autologous TILs." @default.
• W2091201553 created "2016-06-24" @default.
• W2091201553 creator A5007369869 @default.
• W2091201553 creator A5007865413 @default.
• W2091201553 creator A5016145911 @default.
• W2091201553 creator A5024528047 @default.
• W2091201553 creator A5037991056 @default.
• W2091201553 creator A5067581165 @default.
• W2091201553 creator A5075050268 @default.
• W2091201553 creator A5089860825 @default.
• W2091201553 creator A5091468377 @default.
• W2091201553 date "1990-01-01" @default.
• W2091201553 modified "2023-09-26" @default.
• W2091201553 title "Human gene transfer: characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man." @default.
• W2091201553 cites W1562422876 @default.
• W2091201553 cites W1570009082 @default.
• W2091201553 cites W1599327500 @default.
• W2091201553 cites W1631971313 @default.
• W2091201553 cites W1942232650 @default.
• W2091201553 cites W1967112185 @default.
• W2091201553 cites W1977157092 @default.
• W2091201553 cites W1989783048 @default.
• W2091201553 cites W2006437800 @default.
• W2091201553 cites W2008685326 @default.
• W2091201553 cites W2012739094 @default.
• W2091201553 cites W2014669590 @default.
• W2091201553 cites W2021152296 @default.
• W2091201553 cites W2021461055 @default.
• W2091201553 cites W2025696302 @default.
• W2091201553 cites W2037585283 @default.
• W2091201553 cites W2053677240 @default.
• W2091201553 cites W2060333964 @default.
• W2091201553 cites W2066913325 @default.
• W2091201553 cites W2067229421 @default.
• W2091201553 cites W2079588771 @default.
• W2091201553 cites W2098157239 @default.
• W2091201553 cites W2107455919 @default.
• W2091201553 cites W2142800802 @default.
• W2091201553 cites W2145623185 @default.
• W2091201553 cites W2161545291 @default.
• W2091201553 cites W2162299766 @default.
• W2091201553 cites W2168697593 @default.
• W2091201553 cites W2335365056 @default.
• W2091201553 doi "https://doi.org/10.1073/pnas.87.1.473" @default.
• W2091201553 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/53286" @default.
• W2091201553 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2404283" @default.
• W2091201553 hasPublicationYear "1990" @default.
• W2091201553 type Work @default.
• W2091201553 sameAs 2091201553 @default.
• W2091201553 citedByCount "133" @default.
• W2091201553 countsByYear W20912015532013 @default.
• W2091201553 countsByYear W20912015532015 @default.
• W2091201553 countsByYear W20912015532020 @default.
• W2091201553 countsByYear W20912015532021 @default.
• W2091201553 crossrefType "journal-article" @default.
• W2091201553 hasAuthorship W2091201553A5007369869 @default.
• W2091201553 hasAuthorship W2091201553A5007865413 @default.
• W2091201553 hasAuthorship W2091201553A5016145911 @default.
• W2091201553 hasAuthorship W2091201553A5024528047 @default.
• W2091201553 hasAuthorship W2091201553A5037991056 @default.
• W2091201553 hasAuthorship W2091201553A5067581165 @default.
• W2091201553 hasAuthorship W2091201553A5075050268 @default.
• W2091201553 hasAuthorship W2091201553A5089860825 @default.
• W2091201553 hasAuthorship W2091201553A5091468377 @default.
• W2091201553 hasBestOaLocation W20912015531 @default.
• W2091201553 hasConcept C104317684 @default.
• W2091201553 hasConcept C111599444 @default.
• W2091201553 hasConcept C147483822 @default.
• W2091201553 hasConcept C153911025 @default.
• W2091201553 hasConcept C167672396 @default.
• W2091201553 hasConcept C203014093 @default.
• W2091201553 hasConcept C2776090121 @default.
• W2091201553 hasConcept C2777371288 @default.
• W2091201553 hasConcept C2778326572 @default.
• W2091201553 hasConcept C2778690821 @default.
• W2091201553 hasConcept C32470452 @default.
• W2091201553 hasConcept C40767141 @default.
• W2091201553 hasConcept C502942594 @default.
• W2091201553 hasConcept C54355233 @default.
• W2091201553 hasConcept C86803240 @default.
• W2091201553 hasConcept C8891405 @default.
• W2091201553 hasConcept C90375314 @default.
• W2091201553 hasConceptScore W2091201553C104317684 @default.
• W2091201553 hasConceptScore W2091201553C111599444 @default.
• W2091201553 hasConceptScore W2091201553C147483822 @default.
• W2091201553 hasConceptScore W2091201553C153911025 @default.
• W2091201553 hasConceptScore W2091201553C167672396 @default.
• W2091201553 hasConceptScore W2091201553C203014093 @default.
• W2091201553 hasConceptScore W2091201553C2776090121 @default.
• W2091201553 hasConceptScore W2091201553C2777371288 @default.
• W2091201553 hasConceptScore W2091201553C2778326572 @default.
• W2091201553 hasConceptScore W2091201553C2778690821 @default.
• W2091201553 hasConceptScore W2091201553C32470452 @default.
• W2091201553 hasConceptScore W2091201553C40767141 @default.
• W2091201553 hasConceptScore W2091201553C502942594 @default.
• W2091201553 hasConceptScore W2091201553C54355233 @default.
• W2091201553 hasConceptScore W2091201553C86803240 @default.
• W2091201553 hasConceptScore W2091201553C8891405 @default.

• next